1. Exploring structural features of EGFR–HER2 dual inhibitors as anti-cancer agents using G-QSAR approach. (4th May 2019) Authors: Fatima, Shehnaz; Agarwal, Subhash Mohan Journal: Journal of receptor and signal transduction research Issue: Volume 39:Number 3(2019) Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Insight into structural requirements of antiamoebic flavonoids: 3D‐QSAR and G‐QSAR studies. (26th June 2018) Authors: Fatima, Shehnaz; Gupta, Payal; Agarwal, Subhash Mohan Journal: Chemical biology & drug design Issue: Volume 92:Number 4(2018) Page Start: 1743 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacokinetic profiling of anticancer phytocompounds using computational approach. Issue 6 (18th April 2018) Authors: Sharma, Ashish; Sharma, Shilpa; Gupta, Mansi; Fatima, Shehnaz; Saini, Ravi; Agarwal, Subhash Mohan Journal: Phytochemical analysis Issue: Volume 29:Issue 6(2018) Page Start: 559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. QSAR of clinically important EGFR mutant L858R/T790M pyridinylimidazole inhibitors. (15th April 2019) Authors: Fatima, Shehnaz; Pal, Divyani; Agarwal, Subhash Mohan Journal: Chemical biology & drug design Issue: Volume 94:Number 1(2019) Page Start: 1306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Synthesis of metronidazole based thiazolidinone analogs as promising antiamoebic agents. Issue 23 (1st December 2020) Authors: Ansari, Mohammad Fawad; Inam, Afreen; Ahmad, Kamal; Fatima, Shehnaz; Agarwal, Subhash M.; Azam, Amir Journal: Bioorganic & medicinal chemistry letters Issue: Volume 30:Issue 23(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. TMLRpred: A machine learning classification model to distinguish reversible EGFR double mutant inhibitors. (15th October 2020) Authors: Saini, Ravi; Fatima, Shehnaz; Agarwal, Subhash Mohan Journal: Chemical biology & drug design Issue: Volume 96:Number 3(2020) Page Start: 921 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Unraveling structural requirements of amino-pyrimidine T790M/L858R double mutant EGFR inhibitors: 2D and 3D QSAR study. (4th July 2018) Authors: Fatima, Shehnaz; Agarwal, Subhash Mohan Journal: Journal of receptor and signal transduction research Issue: Volume 38:Number 4(2018) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. VOCC: a database of volatile organic compounds in cancer. Issue 115 (9th December 2016) Authors: Agarwal, Subhash Mohan; Sharma, Mansi; Fatima, Shehnaz Journal: RSC advances Issue: Volume 6:Issue 115(2016) Page Start: 114783 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗